SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000812796-07-000066
Filing Date
2007-08-14
Accepted
2007-08-14 14:03:39
Documents
2
Period of Report
2007-08-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 2Q - 2007 PRESS RELEASE OF FINANCIAL RESULTS pressrelease2q2007.htm 8-K 19917
2 PRESS RELEASE ISSUED FOR 2Q 2007 issuedpressrelease2q2007.htm EX-99.1 28346
  Complete submission text file 0000812796-07-000066.txt   49992
Mailing Address 1101 BRICKELL AVENUE SUITE 701 S MIAMI FL 33131
Business Address 1101 BRICKELL AVENUE SUITE 701 S MIAMI FL 33131 305-534-3383
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16929 | Film No.: 071053623
SIC: 2834 Pharmaceutical Preparations